Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations
- PMID: 26501534
- PMCID: PMC6586223
- DOI: 10.1001/jama.2015.12790
Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations
Abstract
Importance: The Advisory Committee on Immunization Practices (ACIP) recommends the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine for pregnant women during each pregnancy, regardless of prior immunization status. However, safety data on repeated Tdap vaccination in pregnancy is lacking.
Objective: To determine whether receipt of Tdap vaccine during pregnancy administered in close intervals from prior tetanus-containing vaccinations is associated with acute adverse events in mothers and adverse birth outcomes in neonates.
Design, setting, and participants: A retrospective cohort study in 29,155 pregnant women aged 14 through 49 years from January 1, 2007, through November 15, 2013, using data from 7 Vaccine Safety Datalink sites in California, Colorado, Minnesota, Oregon, Washington, and Wisconsin.
Exposures: Women who received Tdap in pregnancy following a prior tetanus-containing vaccine less than 2 years before, 2 to 5 years before, and more than 5 years before.
Main outcomes and measures: Acute adverse events (fever, allergy, and local reactions) and adverse birth outcomes (small for gestational age, preterm delivery, and low birth weight) were evaluated. Women who were vaccinated with Tdap in pregnancy and had a prior tetanus-containing vaccine more than 5 years before served as controls.
Results: There were no statistically significant differences in rates of medically attended acute adverse events or adverse birth outcomes related to timing since prior tetanus-containing vaccination. [table: see text].
Conclusions and relevance: Among women who received Tdap vaccination during pregnancy, there was no increased risk of acute adverse events or adverse birth outcomes for those who had been previously vaccinated less than 2 years before or 2 to 5 years before compared with those who had been vaccinated more than 5 years before. These findings suggest that relatively recent receipt of a prior tetanus-containing vaccination does not increase risk after Tdap vaccination in pregnancy.
Conflict of interest statement
Figures
Comment in
-
Repeat Tdap Vaccination and Adverse Birth Outcomes.JAMA. 2016 Mar 22-29;315(12):1285-6. doi: 10.1001/jama.2015.19078. JAMA. 2016. PMID: 27002454 No abstract available.
-
Repeat Tdap Vaccination and Adverse Birth Outcomes--Reply.JAMA. 2016 Mar 22-29;315(12):1286. doi: 10.1001/jama.2015.19087. JAMA. 2016. PMID: 27002457 Free PMC article. No abstract available.
Similar articles
-
Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes.JAMA. 2014 Nov 12;312(18):1897-904. doi: 10.1001/jama.2014.14825. JAMA. 2014. PMID: 25387187 Free PMC article.
-
Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy.Obstet Gynecol. 2015 Nov;126(5):1069-74. doi: 10.1097/AOG.0000000000001066. Obstet Gynecol. 2015. PMID: 26444109 Free PMC article.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.Vaccine. 2017 Oct 9;35(42):5603-5610. doi: 10.1016/j.vaccine.2017.08.041. Epub 2017 Sep 12. Vaccine. 2017. PMID: 28916245
-
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.Public Health. 2020 Feb;179:38-44. doi: 10.1016/j.puhe.2019.10.001. Epub 2019 Nov 11. Public Health. 2020. PMID: 31726399 Review.
Cited by 27 articles
-
Vaccine Safety: Myths and Misinformation.Front Microbiol. 2020 Mar 17;11:372. doi: 10.3389/fmicb.2020.00372. eCollection 2020. Front Microbiol. 2020. PMID: 32256465 Free PMC article. Review.
-
Safety of Maternal Immunization Against Pertussis: A Systematic Review.Infect Dis Ther. 2019 Dec;8(4):543-568. doi: 10.1007/s40121-019-00265-6. Epub 2019 Sep 17. Infect Dis Ther. 2019. PMID: 31531826 Free PMC article. Review.
-
Safety, equity and monitoring: a review of the gaps in maternal vaccination strategies for Aboriginal and Torres Strait Islander women.Hum Vaccin Immunother. 2020;16(2):371-376. doi: 10.1080/21645515.2019.1649552. Epub 2019 Sep 6. Hum Vaccin Immunother. 2020. PMID: 31368832
-
Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review.BMJ Glob Health. 2019 Jul 8;4(4):e001065. doi: 10.1136/bmjgh-2018-001065. eCollection 2019. BMJ Glob Health. 2019. PMID: 31354969 Free PMC article.
-
Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study.Hum Vaccin Immunother. 2019;15(12):2873-2881. doi: 10.1080/21645515.2019.1627161. Epub 2019 Jun 20. Hum Vaccin Immunother. 2019. PMID: 31216218 Free PMC article. Clinical Trial.